Showing results (1731-1740 of 1,909) with videos related to
Sort By:
Pageof 191
JAMA Oncology|October 26, 2023
Sustained Survival Benefit in Recurrent Medulloblastoma by a Metronomic Antiangiogenic Regimen: A Nonrandomized Controlled TrialAndreas Peyrl, Monika Chocholous, Magnus Sabel, et al.Acta Neuropathologica|May 6, 2014
Prognostic significance of clinical, histopathological, and molecular characteristics of medulloblastomas in the prospective HIT2000 multicenter clinical trial cohortTorsten Pietsch, Rene Schmidt, Marc Remke, et al.Acta Neuropathologica|December 2, 2022
Identification of low and very high-risk patients with non-WNT/non-SHH medulloblastoma by improved clinico-molecular stratification of the HIT2000 and I-HIT-MED cohortsMartin Mynarek, Denise Obrecht, Martin Sill, et al.Acta Neuropathologica|December 14, 2011
Biological and clinical heterogeneity of MYCN-amplified medulloblastomaAndrey Korshunov, Marc Remke, Marcel Kool, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|March 25, 2018
Array-based DNA-methylation profiling in sarcomas with small blue round cell histology provides valuable diagnostic informationChristian Koelsche, Wolfgang Hartmann, Daniel Schrimpf, et al.Acta Neuropathologica|April 5, 2016
Risk stratification of childhood medulloblastoma in the molecular era: the current consensusVijay Ramaswamy, Marc Remke, Eric Bouffet, et al.Nature Medicine|September 12, 2017
A mouse model for embryonal tumors with multilayered rosettes uncovers the therapeutic potential of Sonic-hedgehog inhibitorsJulia E Neumann, Annika K Wefers, Sander Lambo, et al.Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 19, 2016
Treatment of Children and Adolescents With Metastatic Medulloblastoma and Prognostic Relevance of Clinical and Biologic ParametersAndré O von Bueren, Rolf-Dieter Kortmann, Katja von Hoff, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2020
Delta-24-RGD, an Oncolytic Adenovirus, Increases Survival and Promotes Proinflammatory Immune Landscape Remodeling in Models of AT/RT and CNS-PNETMarc Garcia-Moure, Marisol Gonzalez-Huarriz, Sara Labiano, et al.Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|November 1, 2021
Spatial Dissection of Invasive Front from Tumor Mass Enables Discovery of Novel microRNA Drivers of Glioblastoma InvasionYulun Huang, Lin Qi, Mari Kogiso, et al.Pageof 191